• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Humira

Robert Michael AbbVie CEO AbbVie CEO
Pharma

AbbVie's Rob Michael collected $18.5M in '24 CEO debut

For his work in 2024, AbbVie helmsman Robert Michael—who took over as CEO from Richard Gonzalez on July 1—collected nearly $18.5 million in total pay.
Fraiser Kansteiner Mar 11, 2025 1:11pm
AbbVie

As IBD sales boom, AbbVie increases Skyrizi, Rinvoq projection

Jan 31, 2025 11:41am
AbbVie

AbbVie makes 'Rheum for Dialogue' with new patient resource

Nov 18, 2024 10:20am
A small plant growing in a crack in the ground with a shadow of a tree behind it

Biologics gaining ground in HS, but more support needed: Spherix

Nov 11, 2024 11:52am
AbbVie

AbbVie's Skyrizi overtakes Humira as top sales driver

Oct 30, 2024 12:46pm
Humira

Docs discuss ongoing Humira use, name preferred biosimilars

Sep 24, 2024 7:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings